Literature DB >> 3023437

Homotypic and heterotypic antibodies for prevention of experimental rotavirus gastroenteritis.

G A Losonsky, S L Vonderfecht, J Eiden, S B Wee, R H Yolken.   

Abstract

We investigated the abilities of homologous and heterologous antibody preparations to neutralize murine rotavirus in a mouse model of rotavirus infection. We found that incubation of virus with murine sera obtained from animals experimentally infected with the homologous epizootic diarrhea of infant mice strain of rotavirus resulted in inability of the virus to cause symptomatic disease in infant mice. Sera from nonimmune mice and mice infected or immunized with a heterotypic strain of rotavirus did not effectively neutralize virus in this system. On the other hand, neutralization was noted after incubation of virus with a number of immunoglobulins from other animal and human sources. The neutralizing activity of the preparations in the murine model correlated partially, but not completely, with the level of in vitro neutralizing antibody to the murine strain of rotavirus measured in a tissue culture system. In most cases, asymptomatic infection after feeding of the virus and the antibody preparation resulted in subsequent generation of an active immune response in infected animals.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023437      PMCID: PMC269095          DOI: 10.1128/jcm.24.6.1041-1044.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Rotavirus neutralizing protein VP7: antigenic determinants investigated by sequence analysis and peptide synthesis.

Authors:  P R Gunn; F Sato; K F Powell; A R Bellamy; J R Napier; D R Harding; W S Hancock; L J Siegman; G W Both
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

2.  Kinetics of viral replication and local and systemic immune responses in experimental rotavirus infection.

Authors:  R S Eydelloth; S L Vonderfecht; J F Sheridan; L D Enders; R H Yolken
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

3.  Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus.

Authors:  H B Greenberg; J Valdesuso; K van Wyke; K Midthun; M Walsh; V McAuliffe; R G Wyatt; A R Kalica; J Flores; Y Hoshino
Journal:  J Virol       Date:  1983-08       Impact factor: 5.103

4.  Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes.

Authors:  R G Wyatt; H D James; A L Pittman; Y Hoshino; H B Greenberg; A R Kalica; J Flores; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

5.  Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies.

Authors:  P A Offit; H F Clark
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

6.  Antibody to human rotavirus in cow's milk.

Authors:  R H Yolken; G A Losonsky; S Vonderfecht; F Leister; S B Wee
Journal:  N Engl J Med       Date:  1985-03-07       Impact factor: 91.245

7.  Eggs: conveniently packaged antibodies. Methods for purification of yolk IgG.

Authors:  J C Jensenius; I Andersen; J Hau; M Crone; C Koch
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

8.  Sequential passages of human rotavirus in MA-104 cells.

Authors:  T Urasawa; S Urasawa; K Taniguchi
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

9.  Antigenic relationships among some bovine rotaviruses: serum neutralization and cross-protection in gnotobiotic calves.

Authors:  G N Woode; N E Kelso; T F Simpson; S K Gaul; L E Evans; L Babiuk
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

10.  Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization.

Authors:  Y Hoshino; R G Wyatt; H B Greenberg; J Flores; A Z Kapikian
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

View more
  5 in total

1.  Development of an adult mouse model for studies on protection against rotavirus.

Authors:  R L Ward; M M McNeal; J F Sheridan
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

Review 2.  Human viral gastroenteritis.

Authors:  M L Christensen
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

3.  Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea.

Authors:  Celina G Vega; Marina Bok; Anastasia N Vlasova; Kuldeep S Chattha; Silvia Gómez-Sebastián; Carmen Nuñez; Carmen Alvarado; Rodrigo Lasa; José M Escribano; Lorena L Garaicoechea; Fernando Fernandez; Karin Bok; Andrés Wigdorovitz; Linda J Saif; Viviana Parreño
Journal:  PLoS Pathog       Date:  2013-05-02       Impact factor: 6.823

4.  IgY antibodies protect against human Rotavirus induced diarrhea in the neonatal gnotobiotic piglet disease model.

Authors:  Celina G Vega; Marina Bok; Anastasia N Vlasova; Kuldeep S Chattha; Fernando M Fernández; Andrés Wigdorovitz; Viviana G Parreño; Linda J Saif
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

Review 5.  Rotaviruses: immunological determinants of protection against infection and disease.

Authors:  P A Offit
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.